SEER Inquiry System - Question 20051047 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 11/24/2024 9:30 PM

Question 20051047

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

Micromedex. http://druginfo.cc.nih.gov

Question:

First Course Treatment--Immunotherapy: Is anti-thymocyte globulin coded as immunotherapy?

Discussion:

Answer:

Do not code anti-thymocyte globulin as cancer treatment. Anti-thymocyte globulin is used to treat transplant rejection.

Cancer Site Category:

N/A

Data Item Category:

First course treatment, Immunotherapy

Other Category:

N/A

Year:

2005